PMID- 12581899 OWN - NLM STAT- MEDLINE DCOM- 20030307 LR - 20190816 IS - 0165-4608 (Print) IS - 0165-4608 (Linking) VI - 141 IP - 1 DP - 2003 Feb TI - A novel tumorigenic human prostate epithelial cell line (M2205): molecular cytogenetic characterization demonstrates C-MYC amplification and jumping translocations. PG - 56-64 AB - The paucity of cell lines from early-stage prostate cancer tumors has hindered the recognition of genetic and cellular changes that are associated with the acquisition of tumorigenesis. We describe the chromosomal complement of a novel tumorigenic prostate epithelial cell subline, called M2205, that acquired only three new, consistent chromosomal changes (from those present in the SV40T antigen immortalized parental cell line, P69SV40TAg) when it attained tumor-forming potential. The consistent changes, which were fully characterized using GTG-banding, CBG-banding, silver staining, fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), and spectral karyotyping (SKY), involved segmental jumping translocations and resulted in gains in the copy number of genes located on the distal long arm of chromosome 8 (8q22 to 8q24.3), including c-myc. Furthermore, the jumping translocations also resulted in ribosomal genes being present in multiple, tandem copies next to the chromatin from 8q. Given the relatively small number of cytogenetic changes present, this subline provides a means for better understanding the cellular changes associated with the acquired chromosomal imbalances. Further studies of this subline could also provide insight as to the mechanism or mechanisms leading to the formation of jumping translocations, as well as potential position effects resulting from the relocation of ribosomal genes next to other cellular genes or oncogenes. FAU - Jackson-Cook, Colleen AU - Jackson-Cook C AD - Department of Human Genetics, Medical College of Virginia Campus of Virginia Commonwealth University, Richmond, VA 23298-0033, USA. jacksonc@hsc.vcu.edu FAU - Zou, Ying AU - Zou Y FAU - Turner, Kristi AU - Turner K FAU - Astbury, Caroline AU - Astbury C FAU - Ware, Joy AU - Ware J LA - eng GR - R01 DK052683/DK/NIDDK NIH HHS/United States GR - R01CA58126/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Cancer Genet Cytogenet JT - Cancer genetics and cytogenetics JID - 7909240 SB - IM MH - Cell Transformation, Neoplastic/*genetics MH - Chromosomes, Human/genetics MH - Epithelial Cells/*pathology MH - Gene Amplification/*genetics MH - Genes, myc/*genetics MH - Humans MH - In Situ Hybridization, Fluorescence MH - Karyotyping MH - Male MH - Prostatic Neoplasms/*genetics/pathology MH - Translocation, Genetic/*genetics MH - Tumor Cells, Cultured EDAT- 2003/02/13 04:00 MHDA- 2003/03/08 04:00 CRDT- 2003/02/13 04:00 PHST- 2003/02/13 04:00 [pubmed] PHST- 2003/03/08 04:00 [medline] PHST- 2003/02/13 04:00 [entrez] AID - S0165460802006659 [pii] AID - 10.1016/s0165-4608(02)00665-9 [doi] PST - ppublish SO - Cancer Genet Cytogenet. 2003 Feb;141(1):56-64. doi: 10.1016/s0165-4608(02)00665-9.